Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Bronte, Vincenzo, Brandau, Sven, Chen, Shu-Hsia, Colombo, Mario P., Frey, Alan B., Greten, Tim F., Mandruzzato, Susanna, Murray, Peter J. +7 more·2016·Nature Communications

DOI 10.1038/ncomms12150

Cited by (1,003)

Items 501–600 of 1,003

Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival
Oscar E. Brück, Olli Dufva, Helena R. Hohtari, Sami Blom, Riku Turkki, Mette Matilda Ilander, Panu E. Kovanen, Céline Pallaud, Pedro Marques Ramos, Hanna Lähteenmäki et al. · 2020 · Blood Advances
The Immune Microenvironment in Mesothelioma: Mechanisms of Resistance to Immunotherapy
Chu, Gerard J., van Zandwijk, Nico, Rasko, John E. J. · 2019 · Frontiers in Oncology
Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata
Margot Zöller, Kun Zhao, N. Natali Kutlu, Nathalie Bauer, Jan Provazník, Thilo Hackert, Martina Schnölzer · 2018 · Frontiers in Immunology
Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node
Kim M. van Pul, Ronald J.C.L.M. Vuylsteke, Rieneke van de Ven, Elisabeth A. te Velde, Emiel J. Th. Rutgers, M. Petrousjka van den Tol, Hein B.A.C. Stockmann, Tanja D. de Gruijl · 2019 · Journal for ImmunoTherapy of Cancer
ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells
Latika Singh, Eric S. Muise, Anannya Bhattacharya, Jeff Grein, Sarah Javaid, Peter Stivers, Jun Zhang, Yujie Qu, Barbara Joyce-Shaikh, Andrey P. Loboda et al. · 2020 · Molecular Cancer Research
Roles of tumor-associated neutrophils in tumor metastasis and its clinical applications
Man Yan, Minying Zheng, Rui Niu, Xiaohui Yang, Shifeng Tian, Linlin Fan, Yuwei Li, Shiwu Zhang · 2022 · Frontiers in Cell and Developmental Biology
Remodeling tumor microenvironment with natural products to overcome drug resistance
Wanlu Zhang, Shubo Li, Chunting Li, Tianye Li, Yongye Huang · 2022 · Frontiers in Immunology
γ‐Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma
Liang Mao, Zhi‐Li Zhao, Guang‐Tao Yu, Lei Wu, Wei‐Wei Deng, Yicun Li, Jianfeng Liu, Lin‐Lin Bu, Bing Liu, Ashok B. Kulkarni et al. · 2017 · International Journal of Cancer
p16Ink4a and p21Cip1/Waf1 promote tumour growth by enhancing myeloid-derived suppressor cells chemotaxis
Okuma, Atsushi, Hanyu, Aki, Watanabe, Sugiko, Hara, Eiji · 2017 · Nature Communications
Tumor‐associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy
Chiara Porta, Antonio Sica, Elena Riboldi · 2017 · FEBS Journal
Myeloid signature reveals immune contexture and predicts the prognosis of hepatocellular carcinoma
Chong Wu, Jie Lin, Yulan Weng, Dan-Ni Zeng, Jing Xu, Shufeng Luo, Li Xu, Mingyu Liu, Qiaomin Hua, Chaoqun Liu et al. · 2020 · Journal of Clinical Investigation
Splenic Hematopoietic and Stromal Cells in Cancer Progression
Jonas Steenbrugge, Emiel A. De Jaeghere, Evelyne Meyer, Hannelore G Denys, Olivier De Wever · 2020 · Cancer Research
Single-Cell RNA-seq of Human Myeloid-Derived Suppressor Cells in Late Sepsis Reveals Multiple Subsets With Unique Transcriptional Responses: A Pilot Study
Dijoia B. Darden, Rhonda L. Bacher, Maigan Brusko, Parker Knight, Russell B. Hawkins, Michael C. Cox, Marvin L. S. Dirain, Ricardo F. Ungaro, Dina C. Nacionales, Jaimar C. Rincon et al. · 2020 · Shock
Type I interferon response in astrocytes promotes brain metastasis by enhancing monocytic myeloid cell recruitment
Weili Ma, Maria Cecília Oliveira-Nunes, Ke Xu, Andrew V. Kossenkov, Benjamin C. Reiner, Richard C. Crist, James E. Hayden, Qing Chen · 2023 · Nature Communications
Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics
Tosin Akinsipe, Rania Mohamedelhassan, Ayuba Akinpelu, Satyanarayana R. Pondugula, Panagiotis Mistriotis, L. Adriana Avila, Amol S. Suryawanshi · 2024 · Frontiers in Immunology
SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells
Priscilla S. Redd, Mohammed L. Ibrahim, John David Klement, Sarah K. Sharman, Amy V. Paschall, Dafeng Yang, Asha Nayak-Kapoor, Kebin Liu · 2017 · Cancer Research
Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives
Li‐Chun Lu, Chun‐Jung Chang, Chih‐Hung Hsu · 2019 · Journal of Hepatocellular Carcinoma
TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells
Mao, Liang, Xiao, Yao, Yang, Qi-Chao, Yang, Shao-Chen, Yang, Lei-Lei, Sun, Zhi-Jun · 2021 · Oral Oncology
The Prognostic Role of High Blood Cholesterol in Advanced Cancer Patients Treated With Immune Checkpoint Inhibitors
Fabiana Perrone, Roberta Minari, Melissa Bersanelli, Paola Bordi, Marcello Tiseo, Elda Favari, Roberto Sabato, Sebastiano Buti · 2020 · Journal of Immunotherapy
TGF-β in Cancer: Metabolic Driver of the Tolerogenic Crosstalk in the Tumor Microenvironment
Roberta Angioni, Ricardo Sánchez‐Rodríguez, Antonella Viola, Barbara Molon · 2021 · Cancers
Neutrophil inhibition improves acute inflammation in a murine model of viral myocarditis
Paolo Carai, Laura Florit González, Stijn Van Bruggen, Valérie Spalart, Daria De Giorgio, Nadèche Geuens, Kimberly Martinod, Elizabeth A. V. Jones, Stephane R B Heymans · 2022 · Cardiovascular Research
Unique invariant natural killer T cells promote intestinal polyps by suppressing TH1 immunity and promoting regulatory T cells
Y Wang, Saikiran K. Sedimbi, Linda Löfbom, Avadhesh Kumar Singh, Steven Anthony Porcelli, Susanna Cardell · 2017 · Mucosal Immunology
Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane
Ravi Kumar, Tristan de Mooij, Timothy E. Peterson, Tatiana Kaptzan, Aaron J. Johnson, David J. Daniels, Ian F. Parney · 2017 · PLoS ONE
Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma
Lei Wu, Guang‐Tao Yu, Wei-Wei Deng, Liang Mao, Leilei Yang, Si‐Rui Ma, Lin‐Lin Bu, Ashok B. Kulkarni, Wen‐Feng Zhang, Lu Zhang et al. · 2018 · OncoImmunology
MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target
Tao Zhang, Juhua Zhou, Gene Chi Wai Man, Kam Tong Leung, Bo Liang, Bo Xiao, Xinting Ma, Shaoyan Huang, Huaxiang Huang, Venkatesh L. Hegde et al. · 2018 · European Journal of Immunology
Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment
Robert A. Belderbos, Joachim G.J.V. Aerts, Heleen H. Vroman · 2019 · Molecular Therapy — Oncolytics
Tofacitinib facilitates the expansion of myeloid-derived suppressor cells and ameliorates interstitial lung disease in SKG mice
Sho Sendo, Jun Saegusa, Hirotaka Yamada, Keisuke Nishimura, Akio Morinobu · 2019 · Arthritis Research & Therapy
Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma
Pang, Lizhi, Khan, Fatima, Heimberger, Amy B., Chen, Peiwen · 2022 · Trends in Cancer
Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells
Minjun C. Apodaca, Amy E. Wright, Angela M. Riggins, William P. Harris, Raymond S. W. Yeung, Lei Yu, Chihiro Morishima · 2019 · Journal for ImmunoTherapy of Cancer
Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia
Agata Karolina Pastorczak, Krzysztof Domka, Klaudyna Fidyt, Martyna Poprzeczko, Małgorzata Firczuk · 2021 · Cancers
IDO1/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer
Heng Liang, Tianqi Li, Xin Fang, Zikang Xing, Shengnan Zhang, Lei Shi, Weirui Li, Leilei Guo, Chunxiang Kuang, Hongrui Liu et al. · 2021 · Cancer Letters
Tertiary lymphoid structures and cancer immunotherapy: From bench to bedside
Florent Peyraud, Jean‐Philippe Guégan, Lucile Vanhersecke, Maxime Brunet, Diego Teyssonneau, Lola‐Jade Palmieri, Alban Bessede, Antoîne Italiano · 2025 · Med
Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation
Giada Amodio, Joanna Cichy, Patricia Conde, Gianluca Matteoli, Aurélie Moreau, Jordi Ochando, Barbaros H. Oral, Michaela Pekarová, Elizabeth J. Ryan, Johannes Roth et al. · 2018 · Cancer Immunology Immunotherapy
Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer
M. Chaib, S. Chauhan, Liza Makowski · 2020 · Frontiers in Cell and Developmental Biology
Modulation of gut microbiota mediates berberine‐induced expansion of immuno‐suppressive cells to against alcoholic liver disease
Sha Li, Ning Wang, Hor‐Yue Tan, Fan Chueng, Zhang‐Jin Zhang, Man‐Fung Yuen, Yibin Feng · 2020 · Clinical and Translational Medicine
Immune-based therapies in penile cancer
Vidhu B. Joshi, Philippe E. Spiess, Andrea Necchi, Curtis Alvin Pettaway, Jad Chahoud · 2022 · Nature Reviews Urology
Regulation of T cells by myeloid-derived suppressor cells: emerging immunosuppressor in lung cancer
Zhongning He, Chunyu Zhang, Yuwei Zhao, Shulin He, Yue Li, Bolun Shi, Jiaqi Hu, Runzhi Qi, Baojin Hua · 2023 · Discover Oncology
Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy
Weitao Zhang, Jiawei Li, Guisheng Qi, Guo-Wei Tu, Cheng Yang, Ming Xu · 2018 · Journal of Translational Medicine
Annexin A2/TLR2/MYD88 pathway induces arginase 1 expression in tumor-associated neutrophils
Huajia Zhang, Xiaodong Zhu, Travis J. Friesen, Jeff Kwak, Tatyana Pisarenko, Surapat Mekvanich, Mark A. Velasco, Timothy W. Randolph, Julia Kargl, A. McGarry Houghton · 2022 · Journal of Clinical Investigation
Composite Hydrogel for Spatiotemporal Lipid Intervention of Tumor Milieu
Jia Ma, Daoxia Guo, Xiaoyuan Ji, Yanfeng Zhou, Chang Liu, Qian Li, Jiye Zhang, Chunhai Fan, Haiyun Song · 2023 · Advanced Materials
Defining myeloid-derived suppressor cells
Leila Akkari, Ido Amit, Vincenzo Bronte, Zvi Gregorio Fridlender, Dmitry I. Gabrilovich, Florent Ginhoux, Catherine C. Hedrick, Suzanne Ostrand‐Rosenberg · 2024 · Nature reviews. Immunology
Acquired resistance to innate immune clearance promotes Klebsiella pneumoniae ST258 pulmonary infection
Danielle S. Ahn, Hernán F. Peñaloza, Zheng Wang, Matthew Wickersham, Dane Parker, Purvi R. Patel, Antonius A. Koller, Emily I. Chen, Susan M. Bueno, Anne‐Catrin Uhlemann et al. · 2016 · JCI Insight
Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer
Elena Jachetti, Valeria Cancila, Alice Rigoni, Lucia Bongiovanni, Barbara Cappetti, Beatrice Belmonte, Claudia Enriquez, Patrizia Casalini, Paola Ostano, Barbara Frossi et al. · 2018 · Cancer Immunology Research
Identification of a Novel Subset of Myeloid-Derived Suppressor Cells During Chronic Staphylococcal Infection That Resembles Immature Eosinophils
Oliver Goldmann, Andreas Beineke, Eva Medina · 2017 · The Journal of Infectious Diseases
Targeting Myeloid-Derived Suppressor Cells to Enhance the Antitumor Efficacy of Immune Checkpoint Blockade Therapy
Xueyan Li, Jiahui Zhong, Xue Deng, Xuan Guo, Yantong Lu, Juze Lin, Xuhui Huang, Changjun Wang · 2021 · Frontiers in Immunology
Microbiota-dependent activation of the myeloid calcineurin-NFAT pathway inhibits B7H3- and B7H4-dependent anti-tumor immunity in colorectal cancer
Kenneth Peuker, Anne Strigli, Daniele V. F. Tauriello, Alexander Hendricks, Witigo V Schönfels, Greta Burmeister, Mario Brosch, Alexander Herrmann, Sandra Krüger, Jessica Nitsche et al. · 2022 · Immunity
Neutrophil interactions with T cells, platelets, endothelial cells, and of course tumor cells
Brahm H. Segal, Thejaswini Giridharan, Sora Suzuki, Anm Nazmul H. Khan, Emese Zsíros, Tiffany Rose Emmons, Michael B. Yaffe, Angela A. F. Gankema, Mark Hoogeboom, Ines Goetschalckx et al. · 2022 · Immunological Reviews
Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities
Marcin Kortylewski, Dayson Moreira · 2017 · Cancer Immunology Immunotherapy
TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy
Padmini Jayaraman, Falguni Parikh, Jared M. Newton, Aurélie Hanoteau, Charlotte Helena Rivas, Rosemarie Krupar, Kimal Rajapakshe, Ravi Ramesh Pathak, Kavin Kanthaswamy, Cassie MacLaren et al. · 2018 · OncoImmunology
Immunosuppressive Immature Myeloid Cell Generation Is Controlled by Glutamine Metabolism in Human Cancer
Wenchao Wu, Hong-Wei Sun, Jing Chen, Hanyue Ouyang, Xing-Juan Yu, Haitian Chen, Zeyu Shuang, Ming Shi, Zilian Wang, Limin Zheng · 2019 · Cancer Immunology Research
Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses
Tuuli A. Nissinen, Jaakko Hentilä, Fabio Penna, Anita Lampinen, Juulia H. Lautaoja-Kivipelto, Vasco Fachada, Tanja Holopainen, Olli Ritvos, Riikka Kivelä, Juha J. Hulmi · 2018 · Journal of Cachexia Sarcopenia and Muscle
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses
Fan Huang, Christophe Gonçalves, Margarita Bartish, Joelle Rémy-Sarrazin, Mark E. Issa, Brendan Cordeiro, Qianyu Guo, Audrey Émond, Mikhaël Attias, William Yang et al. · 2021 · Journal of Clinical Investigation
Inhibition of Arginase 1 Liberates Potent T Cell Immunostimulatory Activity of Human Neutrophil Granulocytes
Verena Vonwirth, Yagmur Bülbül, Anke Werner, Hakim Echchannaoui, Johannes Windschmitt, Alice Habermeier, Sonia Ioannidis, Niu Shin, Roland Conradi, Matthias Bros et al. · 2021 · Frontiers in Immunology
Exosomes Derived from Immune Cells: The New Role of Tumor Immune Microenvironment and Tumor Therapy
Shiyang Wang, Yue Xi Shi · 2022 · International Journal of Nanomedicine
CCR2+ monocytic myeloid‐derived suppressor cells (M‐MDSCs) inhibit collagen degradation and promote lung fibrosis by producing transforming growth factor‐β1
Astrid Lebrun, Sandra Lo Re, Mathilde Chantry, Xavier Izquierdo Carerra, Francine Uwambayinema, Doriana Ricci, Raynal Devosse, Saloua Ibouraadaten, Lisa Brombin, Mihaly Palmai‐Pallag et al. · 2017 · The Journal of Pathology
Myeloid-Derived Suppressor Cells Specifically Suppress IFN-γ Production and Antitumor Cytotoxic Activity of Vδ2 T Cells
Alessandra Sacchi, Nicola Tumino, Andrea Sabatini, Eleonora Cimini, Rita Casetti, Veronica Bordoni, Germana Grassi, Chiara Agrati · 2018 · Frontiers in Immunology
Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents
Anne Sophie Kubasch, Freya Schulze, Aristoteles A. N. Giagounidis, Katharina S. S. Götze, Jan Krönke, Katja Sockel, Jan Moritz Middeke, Fatiha Chermat, Silke Gloaguen, Martin Puttrich et al. · 2019 · Leukemia
Neutrophils are mediators of metastatic prostate cancer progression in bone
Diane L. Costanzo-Garvey, Tyler S. Keeley, Adam John Case, Gabrielle F. Watson, Massar Alsamraae, Yangsheng Yu, Kaihong Su, Cortney E. Heim, Tammy Kielian, Colm M. Morrissey et al. · 2020 · Cancer Immunology Immunotherapy
Plasticity and biological diversity of myeloid derived suppressor cells
Kerem Ben‐Meir, Nira Twaik, Michal Baniyash · 2018 · Current Opinion in Immunology
Immunotherapy for Gastric Cancer: Time for a Personalized Approach?
Riccardo Dolcetti, Vallì De Re, Vincenzo Canzonieri · 2018 · International Journal of Molecular Sciences
Targeting Myeloid-Derived Suppressor Cells for Premetastatic Niche Disruption After Tumor Resection
Fan Tang, Yan Tie, Weiqi Hong, Yuquan Wei, Chongqi Tu, Xiawei Wei · 2020 · Annals of Surgical Oncology
New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs
Senthilnath Lakshmanachetty, Joselyn Cruz Cruz, Eric Hoffmeyer, Allison P. Cole, Siddhartha S. Mitra · 2021 · Cells
A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment
Francesca Hofer, G. Di Sario, C. Musiu, S. Sartoris, F. De Sanctis, S. Ugel · 2021 · Cells
Targets of tumor microenvironment for potential drug development
Ling Zhang, Ziruoyu Wang, Kailu Liu, Yihang Liu, Shuai Wang, Wei Jiang, Fanghui Lu, Yongjun Dang · 2024 · MedComm – Oncology
Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients
Masato Kobayashi, Jin‐Sung Chung, Muhammad Shaalan Beg, Yull Edwin Arriaga, Udit N. Verma, Kevin Dale Courtney, John C. Mansour, Barbara Haley, Saad A. Khan, Yutaka Horiuchi et al. · 2018 · Clinical Cancer Research
MDSCs in infectious diseases: regulation, roles, and readjustment
Anca Dorhoi, Estibaliz Glaría, Thalia Garcia-Tellez, Natalie Eva Nieuwenhuizen, Gennadiy Zelinskyy, Benoı̂t Favier, Anurag Singh, Jan Mauno Ehrchen, Cornelia Gujer, Christian Münz et al. · 2018 · Cancer Immunology Immunotherapy
High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity
Ralf Willebrand, Ibrahim Hamad, Lauren Van Zeebroeck, Máté Kiss, Kirsten Bruderek, Anneleen Geuzens, Dries Swinnen, Beatriz F. Côrte‐Real, Lajos Markó, Els Lebegge et al. · 2019 · Frontiers in Immunology
Exploring the Immunological Aspects and Treatments of Recurrent Pregnancy Loss and Recurrent Implantation Failure
Jenny Valentina Garmendia, Claudia Valentina De Sanctis, Marián Hajdúch, Juan Bautista De Sanctis · 2025 · International Journal of Molecular Sciences
Curcumin inhibits the growth of liver cancer by impairing myeloid‑derived suppressor cells in murine tumor tissues
Sha Tian, Liu Liao, Qing Zhou, Xiaodi Huang, Piao Zheng, Yinmei Guo, Tianhao Deng, Xue‐Fei Tian · 2021 · Oncology Letters
The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions
Cameron J. Herting, Isaac Karpovsky, Gregory B. Lesinski · 2021 · Cancer and Metastasis Reviews
Role of adenosine A2b receptor overexpression in tumor progression
Cesar Sepúlveda, Iván F. Palomo, Eduardo Fuentes Q · 2016 · Life Sciences
Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer
Yuji Takeyama, Minoru Kato, Satoshi Tamada, Yukari Azuma, Yasuomi Shimizu, Taro Iguchi, Takeshi Yamasaki, Min Gi, Hideki Wanibuchi, Tatsuya Nakatani · 2020 · Cancer Letters
CAR-T Plus Radiotherapy: A Promising Combination for Immunosuppressive Tumors
Vicky Mengfei Qin, Nicole M. Haynes, Criselle D’Souza, Paul Joseph Neeson, Joe Jiang Zhu · 2022 · Frontiers in Immunology
Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma
Ana Costa, Cécile Thirant, Amira Kramdi, Cécile Pierre‐Eugène, Caroline Louis‐Brennetot, Orphée Blanchard, Didier Surdez, Nadège Gruel, Eve Lapouble, Gaëlle Pierron et al. · 2022 · Journal for ImmunoTherapy of Cancer
Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
Shifen Wang, Xingyun Zhao, Siwen Wu, Dawei Cui, Zhenshu Xu · 2023 · Biomarker Research
Neutrophils at the Crossroads: Unraveling the Multifaceted Role in the Tumor Microenvironment
Deepika Awasthi, Aditya Yashwant Sarode · 2024 · International Journal of Molecular Sciences
Context Drives Diversification of Monocytes and Neutrophils in Orchestrating the Tumor Microenvironment
Juhee Jeong, Yoorock Suh, Keehoon Jung · 2019 · Frontiers in Immunology
Tumor-infiltrating neutrophils predict benefit from adjuvant chemotherapy in patients with muscle invasive bladder cancer
Lin Zhou, Le Xu, Lingli Chen, Qiang Fu, Zheng Liu, Yuan Chang, Zongming Lin, Jiejie Xu · 2017 · OncoImmunology
SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities
Sabina Sangaletti, Giovanna Talarico, Claudia Chiodoni, Barbara Cappetti, Laura Botti, Paola Portararo, Alessandro Gulino, Francesca Maria Consonni, Antonio Sica, Giovanni Randon et al. · 2019 · Frontiers in Immunology
Role of myeloid-derived suppressor cells in the promotion and immunotherapy of colitis-associated cancer
Yungang Wang, Yanxia Ding, Yijun Deng, Yu Zheng, Shengjun Wang · 2020 · Journal for ImmunoTherapy of Cancer
Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients
Sergej Tomić, Jelena Đokić, Dejan Stevanović, Nataša Ilić, Alisa Gruden‐Movsesijan, Miroslav Dinić, Dušan Radojević, Marina Bekić, Nebojša Mitrović, Ratko Tomašević et al. · 2021 · Frontiers in Immunology
Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer
Qiming Zhou, Yao Peng, Fenfen Ji, Huarong Chen, Wei Kang, Lam-Shing Chan, Hongyan Gou, Yufeng Lin, Pingmei Huang, Danyu Chen et al. · 2023 · Nature Communications
Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti–PD-1 resistance
Ashwin Ajith, Kenza Mamouni, Daniel David Horuzsko, Abu Musa, Amiran Dzutsev, Jennifer R. Fang, Ahmed Chadli, Xingguo Zhu, Iryna Lebedyeva, Giorgio Trinchieri et al. · 2023 · Journal of Clinical Investigation
Combination of radiation and interleukin 12 eradicates large orthotopic hepatocellular carcinoma through immunomodulation of tumor microenvironment
Chia-Jen Wu, Yi-Ting Tsai, I‐Jung Lee, Ping‐Yi Wu, Long‐Sheng Lu, Wen-Shan Tsao, Yi-Jou Huang, Ching-Cheng Chang, Shuk‐Man Ka, Mi‐Hua Tao · 2018 · OncoImmunology
Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling
Şehmus Tohumeken, Rebecca Baur, Martin Böttcher, Andrej Stoll, Romy Loschinski, Konstantinos Panagiotidis, Martina Braun, Domenica Saul, Simon Völkl, Andreas S. Baur et al. · 2020 · Cancer Research
Myeloid-Derived Suppressor Cells in Prostate Cancer: Present Knowledge and Future Perspectives
Filippos Koinis, Anastasia Xagara, Evangelia Chantzara, Vassiliki Leontopoulou, Chrissovalantis Aidarinis, Athanasios Panayotis Kotsakis · 2021 · Cells
G‐CSF / GM‐CSF ‐induced hematopoietic dysregulation in the progression of solid tumors
Kai He, Xi Liu, Robert D. Hoffman, Rong-Zhen Shi, Guiyuan Lv, Jian‐Li Gao · 2022 · FEBS Open Bio
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β
Irene Olivera, Rebeca Sanz Pamplona, Elixabet Bolaños, Inmaculada Rodríguez, Iñaki Etxeberría, Assunta Cirella, Josune Egea, Saray Garasa, Itziar Miguéliz, Iñaki Eguren‐Santamaría et al. · 2022 · Cancer Discovery
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy
Balamayooran Theivanthiran, Nagendra Sastry Yarla, Tarek Haykal, Y‐Van Nguyen, Linda Cao, Michelle Ferreira, Alisha Holtzhausen, Rami Nayef Al-Rohil, April K.S. Salama, Georgia Marie Beasley et al. · 2022 · Science Translational Medicine
Here, There, and Everywhere: Myeloid-Derived Suppressor Cells in Immunology
Suzanne Ostrand‐Rosenberg, Tracey J. Lamb, Graham Pawelec · 2023 · The Journal of Immunology
Innate immune cells in tumor microenvironment: A new frontier in cancer immunotherapy
Changhui Li, Xinyu Yu, Xinyan Han, Lian Chen, Zijin Wang, Shiqun Shao, Fangwei Shao, Hua Wang, Shenglin Ma, Jian Liu · 2024 · iScience
Myeloid-Derived Suppressor Cells and Their Potential Application in Transplantation
Joseph R. Scalea, Young Suk Lee, Eduardo Dávila, Jonathan S. Bromberg · 2017 · Transplantation
Interactions among myeloid regulatory cells in cancer
Viktor Umansky, Gosse J. Adema, Jarosław Baran, Sven Brandau, Jo A. Van Ginderachter, Xiaoying Hu, Jadwiga Jabłońska, Slavko B. Mojsilović, Helen Α. Papadaki, Yago Pico de Coaña et al. · 2018 · Cancer Immunology Immunotherapy
Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function
Paul E. Clavijo, J. Friedman, Y. Robbins, E. Moore, E. Smith, M. Zauderer, E. Evans, C. Allen · 2018 · Cancer immunology research
Myeloid‐Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets
Nikoleta Bizymi, Sunčica Bjelica, Astrid Olsnes Kittang, Slavko B. Mojsilović, Maria Velegraki, Charalampos G. Pontikoglou, Mikaël Roussel, Elisabeth Ersvær, Juan Francisco Santibanez, Marie Lipoldová et al. · 2019 · HemaSphere
How Clinical Flow Cytometry Rebooted Sepsis Immunology
Guillaume Monneret, Morgane Gossez, Nima Aghaeepour, Brice L Gaudilliere, Fabienne Venet · 2019 · Cytometry Part A
Therapeutic Targeting of Neutrophil Granulocytes in Inflammatory Liver Disease
Matthias Bartneck, Jing Wang · 2019 · Frontiers in Immunology
Myeloid Cell Mediated Immune Suppression in Pancreatic Cancer
Samantha B. Kemp, Marina Pasca di Magliano, Howard C. Crawford · 2021 · Cellular and Molecular Gastroenterology and Hepatology
Chaperone-assisted E3 ligase CHIP: A double agent in cancer
Sunny Kumar, Malini Basu, Mrinal K. Ghosh · 2021 · Genes & Diseases
3D Cancer Models: Depicting Cellular Crosstalk within the Tumour Microenvironment
Teresa Franchi-Mendes, Rodrigo Eduardo, Giacomo Domenici, Catarina Brito · 2021 · Cancers